13.70
Sotera Health Co stock is traded at $13.70, with a volume of 2.16M.
It is down -0.98% in the last 24 hours and down -15.22% over the past month.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
See More
Previous Close:
$13.84
Open:
$14
24h Volume:
2.16M
Relative Volume:
0.93
Market Cap:
$3.90B
Revenue:
$1.16B
Net Income/Loss:
$77.95M
P/E Ratio:
50.53
EPS:
0.2711
Net Cash Flow:
$144.80M
1W Performance:
-0.36%
1M Performance:
-15.22%
6M Performance:
-11.84%
1Y Performance:
+14.84%
Sotera Health Co Stock (SHC) Company Profile
Name
Sotera Health Co
Sector
Industry
Phone
440-262-1410
Address
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SHC
Sotera Health Co
|
13.70 | 3.93B | 1.16B | 77.95M | 144.80M | 0.2711 |
|
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-26 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-25 | Initiated | William Blair | Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| May-05-25 | Upgrade | Goldman | Neutral → Buy |
| Dec-06-24 | Initiated | Goldman | Neutral |
| May-21-24 | Initiated | Piper Sandler | Neutral |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Mar-25-24 | Upgrade | Jefferies | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Jun-26-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-23-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-11-23 | Upgrade | Barclays | Underweight → Overweight |
| Jan-11-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-15-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-26-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-21-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Sep-20-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-09-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-03-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-02-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-14-21 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Citigroup | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | JP Morgan | Overweight |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | RBC Capital Mkts | Outperform |
View All
Sotera Health Co Stock (SHC) Latest News
Nuclear Medicine (Radiopharmaceuticals) Market Set for Strong Growth at 9.50% CAGR Through 2034: DelveInsight | Lantheus, GE Healthcare, Novartis, Sotera Health and Others - Barchart.com
3 of Wall Street’s Favorite Stocks That Concern Us - Yahoo Finance UK
Sotera Health (SHC) Encounters $16.40 Ceiling as Earnings Strength and Grant Story Drive Breakout Prospects - Bitget
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop - The Motley Fool
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop - The Motley Fool
SHC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Inherent Management Corp. Increases Stake in Sotera Health by $3.31 Million - Intellectia AI
Investment Firm Boosts Holdings in Sterilization Provider Sotera HealthNews and Statistics - IndexBox
Sotera Health Shares Down 24% This Year. Is the Stock a Buy as One Investor Reveals Adding $3 Million More? - The Motley Fool
Sotera Health Co (SHC) director Kenneth D. Krause files initial Form 3 - Stock Titan
A Look At Sotera Health’s Valuation As Earnings Beat And Board Changes Reset Expectations - simplywall.st
Sector Analysis: Research Tools & Consumables Q1 2026 Earnings ReviewNews and Statistics - IndexBox
Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Sotera Health Company (NASDAQ:SHC) - Barchart.com
Sotera Health Co Stock (ISIN: US8293551086) Holds Steady Amid Sterilization Sector Resilience and He - AD HOC NEWS
Aug Levels: What is the target price for Sotera Health Company stock2026 Market Sentiment & Stock Timing and Entry Methods - baoquankhu1.vn
Sotera Health adds pest-control CFO to board after another director exits - Crain's Cleveland
Sotera Health Company (NASDAQ:SHC) Sees Significant Growth in Short Interest - MarketBeat
Sotera Health appoints Kenneth Krause to board of directors By Investing.com - Investing.com Australia
Sotera Health appoints Kenneth D. Krause to board following director resignation - Investing.com Nigeria
Sotera Health appoints Kenneth Krause to board of directors - Investing.com
Kenneth Krause joins Sotera Health (NASDAQ: SHC) board, audit committee - Stock Titan
Sotera Health Appoints Kenneth D. Krause to the Board of Directors - ChartMill
SHC (Sotera Health Co) NonCurrent Deferred Revenue : $17 Mil (As of Dec. 2025) - GuruFocus
Sotera Health at Barclays Conference: Strategic Growth and Legal Challenges - Investing.com
Sotera Health Board Member Trades $229.05M In Company Stock - Benzinga
Insider Transaction: WARBURG PINCUS CO Sells $229.05M Worth Of Sotera Health Shares - Benzinga
Warburg Pincus trims Sotera Health (SHC) stake with 15M-share secondary sale - Stock Titan
Warburg Pincus entities cut Sotera Health (SHC) stake with 15M-share sale - Stock Titan
Warburg Pincus amendment: holds 11.2% of Sotera Health (NYSE: SHC) - Stock Titan
GTCR lists 11.2% stake in Sotera Health (NYSE: SHC) via joint disclosure - Stock Titan
SHC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sotera Health stockholders sell 25 million shares in secondary offering - Investing.com India
Sotera Health stockholders sell 25 million shares in secondary offering By Investing.com - Investing.com Canada
Sotera Health Ownership Shift As 25m Share Sale Tests Valuation - simplywall.st
Sotera Health shares fall 4.2% as private equity firms launch secondary offering - Investing.com Australia
Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Wells Fargo Manages Offering for SHC - GuruFocus
Sotera Health shares fall 4.2% as private equity firms launch secondary offering By Investing.com - Investing.com South Africa
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares? - AOL.com
Sotera Health Announces Secondary Offering of Common Stock - The Manila Times
Sotera Health (SHC) CFO gets new RSUs as shares withheld for tax - Stock Titan
Sotera Health (SHC) Launches 25 Million Share Secondary Offering - GuruFocus
Form 424B7 Sotera Health Co - StreetInsider
Warburg Pincus and GTCR affiliates to sell 25M Sotera Health shares - Stock Titan
SHC SEC FilingsSotera Health Co 10-K, 10-Q, 8-K Forms - Stock Titan
SHC Stock Price and Chart — NASDAQ:SHC - TradingView
Sotera Health Company (SHC) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Sotera Health (SHC) Loses 13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Assessing Sotera Health (SHC) Valuation After Strong 2025 Results And 2026 Growth Guidance - simplywall.st
Sotera Health (SHC) Is Down 7.1% After Issuing 2026 Revenue Guidance And Marking 20th Growth Year - simplywall.st
Sotera Health Co Stock (SHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):